PHARMAQ AS

7863 OVERHALLA

Finances

Return on Equity

23,98 %

Current Ratio

6,17

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	1 568 977 000	1 264 115 000	1 187 450 000	1 103 647 000
Net Income	585 945 000	422 555 000	478 645 000	425 433 000
Total Assets	2 834 967 000	2 149 577 000	1 749 035 000	1 252 424 000
Total Equity	2 443 513 000	1 863 022 000	1 443 897 000	947 067 000

Income (NOK)	2022	2021	2020	2019
Revenue	1 568 977 000	1 264 115 000	1 187 450 000	1 103 647 000
Expenditure	740 210 000	751 385 000	605 963 000	646 441 000
Operating Profit	840 271 000	579 297 000	574 978 000	555 010 000
Financial Income	17 591 000	−35 200 000	38 459 000	21 631 000
Financial Costs	80 018 000	78 000	1 458 000	32 196 000
Financial Balance	−62 427 000	−35 278 000	37 001 000	−10 565 000
Earnings Before Tax	772 656 000	544 020 000	611 979 000	544 445 000
Tax	186 711 000	121 465 000	133 334 000	119 012 000
Net Income	585 945 000	422 555 000	478 645 000	425 433 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	423 961 000	499 632 000	451 996 000	283 851 000
Total Current Assets	2 411 007 000	1 649 945 000	1 297 039 000	968 573 000
Total Assets	2 834 967 000	2 149 577 000	1 749 035 000	1 252 424 000
Total Retained Equity	2 426 100 000	1 845 609 000	1 426 484 000	929 654 000
Total Equity	2 443 513 000	1 863 022 000	1 443 897 000	947 067 000
Total Long-Term Debt	883 000	9 770 000	15 604 000	7 000 000
Total Current Debt	390 571 000	276 785 000	289 535 000	298 357 000
Total Equity and Debt	2 834 967 000	2 149 577 000	1 749 036 000	1 252 424 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	1 551 274 000	1 224 407 000	1 175 896 000	1 094 963 000
Other Income	17 703 000	39 708 000	11 554 000	8 684 000
Revenue	1 568 977 000	1 264 115 000	1 187 450 000	1 103 647 000
Cost of Goods Sold	242 515 000	293 267 000	190 884 000	223 374 000
Salary Costs	277 903 000	252 634 000	248 014 000	237 096 000
Depreciation	38 508 000	37 019 000	35 695 000	25 717 000
Impairment	0	0	0	0
Expenditure	740 210 000	751 385 000	605 963 000	646 441 000
Operating Profit	840 271 000	579 297 000	574 978 000	555 010 000
Financial Income	17 591 000	−35 200 000	38 459 000	21 631 000
Financial Costs	80 018 000	78 000	1 458 000	32 196 000
Financial Balance	−62 427 000	−35 278 000	37 001 000	−10 565 000
Dividends	0	0	0	0
Net Income	585 945 000	422 555 000	478 645 000	425 433 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	30 253 000	40 048 000	49 104 000	58 354 000
Real Eastate	34 742 000	38 647 000	43 671 000	43 611 000
Machinery and Plant Facilities	101 640 000	177 222 000	121 437 000	65 577 000
Fixtures	14 727 000	16 463 000	17 329 000	75 031 000
Total Tangible Assets	233 679 000	232 333 000	182 437 000	184 219 000
Total Fiancial Fixed Assets	160 029 000	227 251 000	220 455 000	41 278 000
Total Fixed Assets	423 961 000	499 632 000	451 996 000	283 851 000
Stock	295 197 000	306 700 000	373 266 000	379 775 000
Total Investments	0	0	0	0
Cash, Bank	0	0	189 000	4 027 000
Total Current Assets	2 411 007 000	1 649 945 000	1 297 039 000	968 573 000
Total Assets	2 834 967 000	2 149 577 000	1 749 035 000	1 252 424 000
Total Equity	2 443 513 000	1 863 022 000	1 443 897 000	947 067 000
Short-Term Group Debt	0	0	0	46 969 000
Total Long-Term Debt	883 000	9 770 000	15 604 000	7 000 000
Creditors	51 578 000	49 055 000	44 702 000	43 041 000
Unpaid Taxes	37 212 000	28 294 000	27 209 000	16 700 000
Dividends	0	0	0	0
Other Current Debt	117 904 000	78 500 000	98 765 000	73 799 000
Total Current Debt	390 571 000	276 785 000	289 535 000	298 357 000
Total Equity and Debt	2 834 967 000	2 149 577 000	1 749 036 000	1 252 424 000

Financial indicators	2022	2021	2020	2019
Return on Equity	23,98 %	22,68 %	33,15 %	44,92 %
Debt-to-Equity Ratio	0	0,01	0,01	0,01
Operating Profit Margin	53,56 %	45,83 %	48,42 %	50,29 %
Current Ratio	6,17	5,96	4,48	3,25
Quick Ratio	25,28	−55,15	−15,49	−11,9
Equity Ratio	0,86	0,87	0,83	0,76
Gross Profit Margin	84,54 %	76,8 %	83,92 %	79,76 %